| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |